chevron-down Created with Sketch Beta.
February 16, 2024

Senate seeking 340B Comments

A bipartisan group of senators released a discussion draft of the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act, also known as the “SUSTAIN 340B Act,” aimed at clarifying Congress’ intent for the 340B program. The legislation seeks to ensure that drug manufacturers participating in Medicaid and Medicare Part B provide discounts and rebates to covered entities serving low-income and underserved patients. For additional information, see Bipartisan 340B Senate Working Group SUSTAIN 340B Act Discussion Draft Explanatory Statement and Supplemental RFI.

The material in all ABA publications is copyrighted and may be reprinted by permission only. Request reprint permission here.